These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21506355)

  • 1. [Ultrasonic cavitation and ozonization in treatment of patients with pyo-necrotic complications of diabetic foot syndrome].
    Zubarev PN; Risman BV
    Vestn Khir Im I I Grek; 2011; 170(1):48-53. PubMed ID: 21506355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Complex treatment of patients with pyo-necrotic complications of the neuropathic form of diabetic foot syndrome].
    Belik BM; Chumburidze IP; Shtilman MY; Yavruyan OA; Savchenko YP
    Khirurgiia (Mosk); 2020; (4):81-87. PubMed ID: 32352675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [ROLE OF ULTRASONIC CAVITATION IN COMPLEX TREATMENT OF SUPPURATIVE-NECROTIC COMPLICATIONS OF DIABETIC FOOT SYNDROME].
    Petrenko OM
    Klin Khir; 2015 Jul; (7):41-3. PubMed ID: 26591218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pyo-necrotic injuries in case of the neuro-ischemic form of diabetic foot syndrome].
    Mitish VA; Pakhalova IuS; Eroshkin IA; Galstian GR; Blatun LA
    Khirurgiia (Mosk); 2014; (1):48-53. PubMed ID: 24429715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Method for improving results of local operations for pyo-necrotic disease of the foot associated with diabetes mellitus].
    Grekova NM; Lebedeva IuV; Bordunovskiĭ VN
    Vestn Khir Im I I Grek; 2003; 162(5):78-81. PubMed ID: 14768112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Repression of bacterial biofilms in suppurative necrotic complications of diabetic foot syndrome by ultrasound cavitation].
    Risman BV; Rybal'chenko OV; Bondarenko VM; Ryzhankova AV
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (4):14-9. PubMed ID: 21913385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Substantiation and varieties of complex surgical treatment tactics for pyo-necrotic forms of diabetic foot].
    Zemlianoĭ AB; Pal'tsyn AA; Svetukhin AM; Korotkina RN; Elagina LV; Pavlova MV; Terekhova RP; Kolokol'chikova EG; Bozh'eva EI; Makhmudova LS; Lebedeva AN; Ivanov LO
    Khirurgiia (Mosk); 1999; (10):44-8. PubMed ID: 10540553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound therapy for recalcitrant diabetic foot ulcers: results of a randomized, double-blind, controlled, multicenter study.
    Ennis WJ; Foremann P; Mozen N; Massey J; Conner-Kerr T; Meneses P
    Ostomy Wound Manage; 2005 Aug; 51(8):24-39. PubMed ID: 16234574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic efficacy of ozone in patients with diabetic foot.
    Martínez-Sánchez G; Al-Dalain SM; Menéndez S; Re L; Giuliani A; Candelario-Jalil E; Alvarez H; Fernández-Montequín JI; León OS
    Eur J Pharmacol; 2005 Oct; 523(1-3):151-61. PubMed ID: 16198334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anesthesia in surgical treatment of pyo-necrotic forms of diabetic foot].
    Ovechkin AM; Khmel'kova EIu; Gnezdilov AV; Gur'eva IV; Voronin AV; Kudriavtsev NG; Panteleev MI
    Khirurgiia (Mosk); 1999; (10):57-9. PubMed ID: 10540556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinicopathologic basis of ozonomagnetophoresis in treatment of festering wounds].
    Zagirov UZ; Isaev UM; Salikhov MA
    Khirurgiia (Mosk); 2008; (12):24-6. PubMed ID: 19156094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An analysis of main causes of low efficiency of rendering care for pyo-necrotic complications of syndrome of the diabetic foot].
    Pavlov IuI
    Vestn Khir Im I I Grek; 2007; 166(5):28-31. PubMed ID: 18154090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ozone-ultrasonic therapy in the treatment of purulent wounds].
    Lipatov KV; Sopromadze MA; Shekhter AB; Rudenko TG; Emel'ianov AIu
    Khirurgiia (Mosk); 2002; (1):36-9. PubMed ID: 11875947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of short-term immunosuppression on the engraftment of skin transplants at syndrome of the diabetic foot].
    Belov VV; Bordunovskiĭ VN; Grekova NM; Lebedeva IuV; Tertyshnik SS
    Vestn Khir Im I I Grek; 2007; 166(5):32-5. PubMed ID: 18154091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of patients with purulent wound infection under conditions of extreme north].
    Khriakov AS; Kozlov KK; Dolgikh VT; Kobiakov DS
    Vestn Khir Im I I Grek; 2009; 168(6):78-81. PubMed ID: 20209999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of peritonitis using ozone and hydropressive technology].
    Bulynin VI; Glukhov AA
    Khirurgiia (Mosk); 1999; (7):9-11. PubMed ID: 10459177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of oxytocin in the combined treatment of suppurative-necrotic lesions of the feet in diabetic patients].
    Gavrilenko VG; Stadnikov AA; Esipov VK; Mit'kin AF
    Vestn Khir Im I I Grek; 2000; 159(3):59-62. PubMed ID: 10983343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of diabetic patients with necrotic lesions of the foot].
    Astakhova IN
    Khirurgiia (Mosk); 2001; (12):34-7. PubMed ID: 11810937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [System and regional antioxidan therapy by complicated diabetic foot].
    Beliaev AN; Rygin EA; Zakhvatov AN; Gulin AN; Gruznov AG
    Khirurgiia (Mosk); 2007; (11):46-50. PubMed ID: 18335589
    [No Abstract]   [Full Text] [Related]  

  • 20. [Morphological justification of the effectiveness of ultrasonic cavitation with 0.2].
    Chekmareva IA; Blatun LA; Paskhalova YS; Mitish VA; Paklina OV; Terekhova RP; Sepeda P; Magomedova SD; Ushakov AA; Sokov SL
    Khirurgiia (Mosk); 2019; (7):63-70. PubMed ID: 31355817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.